(lp0
S'Stock Returns: Enzo Biochem Inc  is Beating Albany Molecular ... CML News - 10 hours ago This is a snapshot to compare the stock returns for Albany Molecular Research Inc  versus Enzo Biochem Inc  .'
p1
aS'BRIEF-Albany Molecular Research enters into agreement with pharmaceutical ... Reuters - Feb 21, 2017 Albany Molecular Research Inc - entered into an agreement with pharmaceutical group Ferrer and Accord Healthcare, Inc. * Albany Molecular - agreement to develop, manufacture undisclosed complex parenteral drug product for registration, subsequent&nbsp;...'
p2
aS"Well recognized Stock of Market: Albany Molecular Research, Inc.'s (AMRI ... Hot Stocks Point - 14 hours ago Albany Molecular Research, Inc.  stock price ended its day with gain 1.55% and finalized at the value of $13.75."
p3
aS'AMRI to Present at Barclays Global Healthcare Conference PR Newswire  - Feb 23, 2017 ALBANY, N.Y., March 3, 2017 /PRNewswire/ -- Albany Molecular Research Inc.  announced today that William S. Marth, President and Chief Executive Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 16&nbsp;...'
p4
aS"Moody's affirms Albany Molecular's B3 CFR following announced acquisition of ... Moodys.com   - May 9, 2016 New York, May 09, 2016 -- Moody's Investors Service  today affirmed Albany Molecular Research Inc.'s  ratings, including its B3 Corporate Family Rating , B3-PD Probability of Default Rating  and the B1 rating on the company's&nbsp;..."
p5
aS"Albany Molecular Research, Regeneron Pharmaceuticals upbeat Albany Times Union - Aug 4, 2016 Two of the region's biopharmaceutical companies released second-quarter results on Thursday, giving investors and analysts insight into their strengths and goals midway through the fiscal year."
p6
aS'Albany Molecular Research Inc.  Moves Higher on Volume Spike for March 15 Equities.com - Mar 15, 2017 Albany Molecular Research Inc.  traded on unusually high volume on Mar. 15, as the stock gained 3.32% to close at $13.70.'
p7
aS'Albany Molecular Research Inc.  Plunges 5.67% on February 22 Equities.com - Feb 22, 2017 Albany Molecular Research Inc.  had a rough trading day for Wednesday February 22 as shares tumbled 5.67%, or a loss of $-0.93 per share, to close at $15.46.Albany Molecular Research, Inc.  Signs Deal With Accord ... - FinancialsTrend'
p8
aS'Albany Molecular Research Inc.  Plunges 5.35% on March 14 Equities.com - Mar 14, 2017 Albany Molecular Research Inc.  had a rough trading day for Tuesday March 14 as shares tumbled 5.35%, or a loss of $-0.75 per share, to close at $13.26.The Russell Investments Group Ltd. Buys Shares of 217126 Albany Molecular ... - Petro Global News 24'
p9
aS'Albany Molecular Research Inc.  Moves Higher on Volume Spike for March 10 Equities.com - Mar 10, 2017 Albany Molecular Research Inc.  traded on unusually high volume on Mar. 10, as the stock gained 2.63% to close at $13.65.Healthcare Oversold Stocks: Genesis Healthcare, Inc. , Albany ... - Benchmark Monitor'
p10
a.